Cargando…

COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities

BACKGROUND: Emory Dialysis serves an urban and predominantly African American population at its four outpatient dialysis facilities. We describe COVID-19 infection control measures implemented and clinical characteristics of patients with COVID-19 in the Emory Dialysis facilities. METHODS: Implement...

Descripción completa

Detalles Bibliográficos
Autores principales: Apata, Ibironke W., Cobb, Jason, Navarrete, Jose, Burkart, John, Plantinga, Laura, Lea, Janice P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936604/
https://www.ncbi.nlm.nih.gov/pubmed/33676397
http://dx.doi.org/10.1186/s12882-021-02281-6
_version_ 1783661219898458112
author Apata, Ibironke W.
Cobb, Jason
Navarrete, Jose
Burkart, John
Plantinga, Laura
Lea, Janice P.
author_facet Apata, Ibironke W.
Cobb, Jason
Navarrete, Jose
Burkart, John
Plantinga, Laura
Lea, Janice P.
author_sort Apata, Ibironke W.
collection PubMed
description BACKGROUND: Emory Dialysis serves an urban and predominantly African American population at its four outpatient dialysis facilities. We describe COVID-19 infection control measures implemented and clinical characteristics of patients with COVID-19 in the Emory Dialysis facilities. METHODS: Implementation of COVID-19 infection procedures commenced in February 2020. Subsequently, COVID-19 preparedness assessments were conducted at each facility. Patients with COVID-19 from March 1–May 31, 2020 were included; with a follow-up period spanning March–June 30, 2020. Percentages of patients diagnosed with COVID-19 were calculated, and characteristics of COVID-19 patients were summarized as medians or percentage. Baseline characteristics of all patients receiving care at Emory Dialysis (i.e. Emory general dialysis population) were presented as medians and percentages. RESULTS: Of 751 dialysis patients, 23 (3.1%) were diagnosed with COVID-19. The median age was 67.0 years and 13 patients (56.6%) were female. Eleven patients (47.8%) were residents of nursing homes. Nineteen patients (82.6%) required hospitalization and 6 patients (26.1%) died; the average number of days from a positive SARS-CoV-2 (COVID) test to death was 16.8 days (range 1–34). Two patients dialyzing at adjacent dialysis stations and a dialysis staff who cared for them, were diagnosed with COVID-19 in a time frame that may suggest transmission in the dialysis facility. In response, universal masking in the facility was implemented (prior to national guidelines recommending universal masking), infection control audits and re-trainings of PPE were also done to bolster infection control practices. CONCLUSION: We successfully implemented recommended COVID-19 infection control measures aimed at mitigating the spread of SARS-CoV-2. Most of the patients with COVID-19 required hospitalizations. Dialysis facilities should remain vigilant and monitor for possible transmission of COVID-19 in the facility.
format Online
Article
Text
id pubmed-7936604
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79366042021-03-08 COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities Apata, Ibironke W. Cobb, Jason Navarrete, Jose Burkart, John Plantinga, Laura Lea, Janice P. BMC Nephrol Research Article BACKGROUND: Emory Dialysis serves an urban and predominantly African American population at its four outpatient dialysis facilities. We describe COVID-19 infection control measures implemented and clinical characteristics of patients with COVID-19 in the Emory Dialysis facilities. METHODS: Implementation of COVID-19 infection procedures commenced in February 2020. Subsequently, COVID-19 preparedness assessments were conducted at each facility. Patients with COVID-19 from March 1–May 31, 2020 were included; with a follow-up period spanning March–June 30, 2020. Percentages of patients diagnosed with COVID-19 were calculated, and characteristics of COVID-19 patients were summarized as medians or percentage. Baseline characteristics of all patients receiving care at Emory Dialysis (i.e. Emory general dialysis population) were presented as medians and percentages. RESULTS: Of 751 dialysis patients, 23 (3.1%) were diagnosed with COVID-19. The median age was 67.0 years and 13 patients (56.6%) were female. Eleven patients (47.8%) were residents of nursing homes. Nineteen patients (82.6%) required hospitalization and 6 patients (26.1%) died; the average number of days from a positive SARS-CoV-2 (COVID) test to death was 16.8 days (range 1–34). Two patients dialyzing at adjacent dialysis stations and a dialysis staff who cared for them, were diagnosed with COVID-19 in a time frame that may suggest transmission in the dialysis facility. In response, universal masking in the facility was implemented (prior to national guidelines recommending universal masking), infection control audits and re-trainings of PPE were also done to bolster infection control practices. CONCLUSION: We successfully implemented recommended COVID-19 infection control measures aimed at mitigating the spread of SARS-CoV-2. Most of the patients with COVID-19 required hospitalizations. Dialysis facilities should remain vigilant and monitor for possible transmission of COVID-19 in the facility. BioMed Central 2021-03-06 /pmc/articles/PMC7936604/ /pubmed/33676397 http://dx.doi.org/10.1186/s12882-021-02281-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Apata, Ibironke W.
Cobb, Jason
Navarrete, Jose
Burkart, John
Plantinga, Laura
Lea, Janice P.
COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
title COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
title_full COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
title_fullStr COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
title_full_unstemmed COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
title_short COVID-19 infection control measures and outcomes in urban dialysis centers in predominantly African American communities
title_sort covid-19 infection control measures and outcomes in urban dialysis centers in predominantly african american communities
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936604/
https://www.ncbi.nlm.nih.gov/pubmed/33676397
http://dx.doi.org/10.1186/s12882-021-02281-6
work_keys_str_mv AT apataibironkew covid19infectioncontrolmeasuresandoutcomesinurbandialysiscentersinpredominantlyafricanamericancommunities
AT cobbjason covid19infectioncontrolmeasuresandoutcomesinurbandialysiscentersinpredominantlyafricanamericancommunities
AT navarretejose covid19infectioncontrolmeasuresandoutcomesinurbandialysiscentersinpredominantlyafricanamericancommunities
AT burkartjohn covid19infectioncontrolmeasuresandoutcomesinurbandialysiscentersinpredominantlyafricanamericancommunities
AT plantingalaura covid19infectioncontrolmeasuresandoutcomesinurbandialysiscentersinpredominantlyafricanamericancommunities
AT leajanicep covid19infectioncontrolmeasuresandoutcomesinurbandialysiscentersinpredominantlyafricanamericancommunities